Overview A Phase II Study of DMP 115 to Assess Focal Liver Lesions Status: Completed Trial end date: 2006-04-01 Target enrollment: Participant gender: Summary To determine the optimal dose of DMP 115 to image liver lesions and to assess whether contrast can improve the detection of focal liver lesions. Phase: Phase 2 Details Lead Sponsor: Lantheus Medical Imaging